Everyone Healthy Library
Basal Cell Carcinoma
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Linked signs and symptoms
19Each sign/symptom opens its own page and links back to related conditions.
- Eye: Sensitive to Light (Photophobia)
- Leg: Restless Leg Syndrome
- Nose Congested or Running (Rhinitis)
- Respiratory Chest Infection
- Salivation
- Seizures
- Septic Embolic
- Shakes
- Skin Bump Flesh Or Brown Coloured
- Skin Bump Pearly
- Skin Bump White or Light Pink
- Skin Bumps Or Lumps
- Skin Redness (Erythema, Rubor)
- Skin Scar Like Sore
- Skin Sore That Bleeds Easily
- Skin Sore That Does Not Heal
- Skin Sore With A Sunken Area in The Middle
- Skin: Sore Oozing Or A Crusting Spot
- Skin: Spot With Irregular Blood Vessels
Linked drugs / medications
1Medication information is educational only. A doctor or pharmacist should advise whether any medicine is appropriate.
Treatments, therapies and supportive options
19Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Surgery
5Medical therapy
9- Annual Medical ExaminationWeakly in Favour(Low Evidence)
- ChemotherapyWeakly in Favour(Low Evidence)
- CryosurgeryWeakly in Favour(Low Evidence)
- ElectrodessicationWeakly in Favour(Low Evidence)
- ExcisionWeakly in Favour(Low Evidence)
- ImmunotherapyWeakly in Favour(Low Evidence)
- Mohs Micrographic SurgeryWeakly in Favour(Low Evidence)
- Photodynamic therapyWeakly in Favour(Low Evidence)
- Radiation TreatmentWeakly in Favour(Low Evidence)
Linked diagnostic tests and investigations
11These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
- Alpha-1 Antitrypsin (AAT) Concentration
- Biopsy
- Fibrin Degradation Products (FDPs, Fibrin Split Products, FSPs, Fibrin Breakdown Products, Fbps)
- Fibrin Monomers Test
- haptoglobin (Hp) concentration
- Potassium Concentration (K, Blood)
- Protein Electrophoresis (Blood, Serum Protein)
- Sinus Culture
- Skin Biopsy
- Skin Prick Test
- Skin Test
Biological and test markers
7This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
6- Alpha-1 Antintrypsin (AAT)Reference range exampleAdult ( > 16y): 90–215 mg/dLLinked diagnostic tests1Alpha-1 Antitrypsin (AAT) Concentration
- Alpha-1-Globulin (Blood, Serum)Reference range exampleAll: 0.1–0.3 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Alpha-2-Globulin (Blood, Serum)Reference range exampleAll: 0.6–1 gm/dLLinked diagnostic tests1Protein Electrophoresis (Blood, Serum Protein)
- Fibrin MonomersReference range example0–10,000 µg/LLinked diagnostic tests1Fibrin Monomers Test
- Fibrin Split ProductsReference range exampleAll: 0–1 mg/dLLinked diagnostic tests1Fibrin Degradation Products (FDPs, Fibrin Split Products
- haptoglobin (Hp)Reference range example45–200 mg/dLLinked diagnostic tests1haptoglobin (Hp) concentration
Often decreased
1Other associated markers
0No markers in this group.
Introduction / full article
Basal Cell Carcinoma
Efficacy of Alternative and Other Treatments According to GRADE* Ranking:
Photodynamic Therapy:
Recommendation: Strong (Photodynamic Therapy is potentially effective in treating Basal Cell Carcinoma in its early stages)
Grade of Evidence: Strong quality of evidence
* www.gradeworkinggroup.org
Basal Cell Carcinoma
Basal cell carcinoma (BCC) is the most common type of skin cancer and falls under the non-melanoma type. [1] Although frequent, only less than 1% of cancer patient deaths are attributed to it. The tumors which grow slowly are classically found on areas exposed to sun. [2]
Epidemiology
American Cancer Society reports that 75% of skin cancer cases are BCC. [3] In the United States, more than 1 million new cases are diagnosed annually causing over 10,000 deaths per year. BCC is most often found in light-skinned people and males are affected twice than females. As a person grows older, the chance of getting BCC gets higher. People aged 50-80 years old are commonly affected with meanage of 55. [2]
Causes
The usual cause of BCC is over-exposure to ultraviolet (UV) rays from sun or sunbeds. BCC may also develop on injured skin due to burns, scars and ulcers. [1] Factors that may increase the chances of having BCC are having light or freckled skin, blond or red hair, blue, green or grey colored eyes and many moles, family history of BCC, over-exposure to sun, x-ray and other radiation forms and history of severe sunburns. [4] Individuals who use sun beds and sun bathe are also at risk. [1]
Signs and Symptoms
BCC may look only a little different from normal skin. It may show as a skin bump or growth thatis pearly or waxy and may appear as white, light pink, brown or same color as flesh. [3] Usually, patients initially notice BCC as a scab with occasional bleeding which heals incompletely. Most are painless and may be itchy. It may also bleed when picked up. [1]
Diagnosis
Physical exam is used to assess the skin lesion. Skin biopsy is often made to confirm BCC and to determine type. When deeper structures are involved like bone, CT scans or radiography may be done. [2
Treatment
There are a number of treatment options for BCC. The choice is based on type, extent and site, numbers to be treated and physician expertise. Management of BCC include superficial skin surgery, excision biopsy, Mohsmicro graphically controlled excision, photodynamic therapy, imiquimod cream, cryotherapy, radiotherapy and vismodegib. [6]
Prognosis
BCC often resolves with treatment. Some may recur and there is also a risk of developing other skin cancers. [6]
References:
1. http://www.bad.org.uk/site/800/Default.aspx
2. http://emedicine.medscape.com/article/276624-overview
3. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001827/
4. http://www.nlm.nih.gov/medlineplus/ency/article/000824.htm
5. http://dermnetnz.org/lesions/basal-cell-carcinoma.html
6. http://dermnetnz.org/lesions/basal-cell-carcinoma.html
Summary References Treatments:
1. Butler DF, Parekh PK, Lenis A (January 2009). "Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular nasal basal cell carcinomas before Mohs micrographic surgery: a randomized, double blind, vehicle-controlled study". Dermatol Surg 35 (1): 24–9.
2. http://www.peplin.com/
3. Peng Q, Juzeniene A, Chen J, et al. (2008). "Lasers in Medicine". Rep. Prog. Phys. 71 (056701): 056701.
4. http://www.webmd.com/cancer/cryosurgery-for-nonmelanoma-skin-cancer
5. http://www.nccn.org/professionals/physician_gls/PDF/nmsc.pdf
6. Silverman MK, Kopf AW, Bart RS, Grin CM, Levenstein MS (June 1992). "Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision". J Dermatol Surg Oncol 18 (6): 471–6.
7. http://www.merck.com/mmpe/sec10/ch128/ch128b.html#sec10-ch128-ch128b-1181c
This information was collected from Wikipedia
This document is released under the GNU Free Documentation License